Do we still need to do dual tracer localisation for sentinel node biopsy in patients with early breast cancer?

Detalles Bibliográficos
Autores principales: Najeeb, Erum, Verroiotou, Maria, Ramzi, Saed, Simonca, Claudiu, Jenkins, Stephanie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Ltd. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7833842/
http://dx.doi.org/10.1016/j.ejso.2020.11.096
_version_ 1783642153666215936
author Najeeb, Erum
Verroiotou, Maria
Ramzi, Saed
Simonca, Claudiu
Jenkins, Stephanie
author_facet Najeeb, Erum
Verroiotou, Maria
Ramzi, Saed
Simonca, Claudiu
Jenkins, Stephanie
author_sort Najeeb, Erum
collection PubMed
description
format Online
Article
Text
id pubmed-7833842
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Published by Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-78338422021-01-26 Do we still need to do dual tracer localisation for sentinel node biopsy in patients with early breast cancer? Najeeb, Erum Verroiotou, Maria Ramzi, Saed Simonca, Claudiu Jenkins, Stephanie Eur J Surg Oncol Article Published by Elsevier Ltd. 2021-01 2020-12-22 /pmc/articles/PMC7833842/ http://dx.doi.org/10.1016/j.ejso.2020.11.096 Text en Copyright © 2020 Published by Elsevier Ltd. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Najeeb, Erum
Verroiotou, Maria
Ramzi, Saed
Simonca, Claudiu
Jenkins, Stephanie
Do we still need to do dual tracer localisation for sentinel node biopsy in patients with early breast cancer?
title Do we still need to do dual tracer localisation for sentinel node biopsy in patients with early breast cancer?
title_full Do we still need to do dual tracer localisation for sentinel node biopsy in patients with early breast cancer?
title_fullStr Do we still need to do dual tracer localisation for sentinel node biopsy in patients with early breast cancer?
title_full_unstemmed Do we still need to do dual tracer localisation for sentinel node biopsy in patients with early breast cancer?
title_short Do we still need to do dual tracer localisation for sentinel node biopsy in patients with early breast cancer?
title_sort do we still need to do dual tracer localisation for sentinel node biopsy in patients with early breast cancer?
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7833842/
http://dx.doi.org/10.1016/j.ejso.2020.11.096
work_keys_str_mv AT najeeberum dowestillneedtododualtracerlocalisationforsentinelnodebiopsyinpatientswithearlybreastcancer
AT verroiotoumaria dowestillneedtododualtracerlocalisationforsentinelnodebiopsyinpatientswithearlybreastcancer
AT ramzisaed dowestillneedtododualtracerlocalisationforsentinelnodebiopsyinpatientswithearlybreastcancer
AT simoncaclaudiu dowestillneedtododualtracerlocalisationforsentinelnodebiopsyinpatientswithearlybreastcancer
AT jenkinsstephanie dowestillneedtododualtracerlocalisationforsentinelnodebiopsyinpatientswithearlybreastcancer

Ejemplares similares